Town & Country Bank & Trust CO dba First Bankers Trust CO Has $823,000 Stock Position in The Clorox Company (NYSE:CLX)

Town & Country Bank & Trust CO dba First Bankers Trust CO reduced its position in shares of The Clorox Company (NYSE:CLX) by 8.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,174 shares of the company’s stock after selling 475 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Clorox were worth $823,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Kennon Green & Company LLC increased its holdings in shares of Clorox by 4.4% during the first quarter. Kennon Green & Company LLC now owns 1,558 shares of the company’s stock worth $247,000 after buying an additional 66 shares in the last quarter. GHP Investment Advisors Inc. increased its holdings in shares of Clorox by 1.3% during the fourth quarter. GHP Investment Advisors Inc. now owns 5,132 shares of the company’s stock worth $720,000 after buying an additional 66 shares in the last quarter. M Holdings Securities Inc. increased its holdings in shares of Clorox by 0.9% during the fourth quarter. M Holdings Securities Inc. now owns 7,523 shares of the company’s stock worth $1,056,000 after buying an additional 68 shares in the last quarter. Toroso Investments LLC increased its holdings in shares of Clorox by 1.3% during the first quarter. Toroso Investments LLC now owns 5,266 shares of the company’s stock worth $833,000 after buying an additional 68 shares in the last quarter. Finally, First Community Trust NA increased its holdings in shares of Clorox by 0.7% during the second quarter. First Community Trust NA now owns 9,755 shares of the company’s stock worth $1,551,000 after buying an additional 70 shares in the last quarter. 77.98% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. StockNews.com upgraded Clorox from a “hold” rating to a “buy” rating in a report on Friday, September 8th. Atlantic Securities raised shares of Clorox from an “underweight” rating to a “neutral” rating in a research report on Thursday, August 3rd. Barclays increased their price objective on shares of Clorox from $117.00 to $127.00 and gave the stock an “underweight” rating in a research report on Friday, August 4th. Finally, DA Davidson upped their target price on shares of Clorox from $155.00 to $176.00 and gave the stock a “neutral” rating in a report on Monday, August 7th. Six research analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $150.38.

Insider Transactions at Clorox

In other news, CFO Kevin B. Jacobsen sold 3,346 shares of the firm’s stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $160.82, for a total transaction of $538,103.72. Following the completion of the sale, the chief financial officer now owns 23,224 shares in the company, valued at approximately $3,734,883.68. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.41% of the stock is currently owned by company insiders.

Clorox Stock Performance

Shares of CLX stock traded down $3.25 during trading hours on Friday, hitting $146.20. 1,703,760 shares of the company were exchanged, compared to its average volume of 1,199,895. The firm has a fifty day simple moving average of $155.09 and a 200 day simple moving average of $157.91. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 6.38. The Clorox Company has a 52-week low of $124.58 and a 52-week high of $178.21. The stock has a market capitalization of $18.10 billion, a price-to-earnings ratio of 122.86, a P/E/G ratio of 2.13 and a beta of 0.28.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.48. Clorox had a net margin of 2.02% and a return on equity of 163.56%. The company had revenue of $2.02 billion during the quarter, compared to analyst estimates of $1.88 billion. During the same quarter last year, the business posted $0.93 EPS. Clorox’s quarterly revenue was up 12.1% compared to the same quarter last year. Research analysts predict that The Clorox Company will post 5.87 earnings per share for the current fiscal year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 25th. Stockholders of record on Wednesday, August 9th were paid a dividend of $1.20 per share. The ex-dividend date was Tuesday, August 8th. This represents a $4.80 annualized dividend and a dividend yield of 3.28%. This is a positive change from Clorox’s previous quarterly dividend of $1.18. Clorox’s dividend payout ratio (DPR) is presently 403.36%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.